Rolf Renne
Impact in
- Oncology top 0.2%
- Viral-associated cancers and disorders
- Epidemiology top 0.2%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
Papers in
-
- Cancer-related molecular mechanisms research 28
- MicroRNA in disease regulation 19
- Oncology 75
- Viral-associated cancers and disorders 70
- Co-authors
- Don GanemBrian HerndierJianhong HuDean H. KedesMark A. SamolsRebecca L. SkalskyMichael LagunoffDirk P. Dittmer
- Journals
- Journal of Virology (26 papers)PLoS Pathogens (13 papers)Virology (7 papers)Nucleic Acids Research (4 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Rolf Renne
105 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 5.7k
- Epidemiology 4.4k
- Cancer Research 1.8k
- Virology 434
- Infectious Diseases 1.3k
Countries citing papers authored by Rolf Renne
This map shows the geographic impact of Rolf Renne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Renne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Renne more than expected).
Fields of papers citing papers by Rolf Renne
This network shows the impact of papers produced by Rolf Renne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Renne. The network helps show where Rolf Renne may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rolf Renne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 26 | |
| 7 | 2019 | 12 | |
| 8 | 2018 | 112 | |
| 9 | 2017 | 27 | |
| 10 | 2016 | 37 | |
| 11 | 2014 | 19 | |
| 12 | 2013 | 1 | |
| 13 | 2011 | 99 | |
| 14 | 2010 | 96 | |
| 15 | 2009 | 84 | |
| 16 | 2007 | 238 | |
| 17 | 2000 | 19 | |
| 18 | 1997 | 247 | |
| 19 | 1996 | 5 | |
| 20 | 1993 | 37 |
About Rolf Renne
Rolf Renne is a scholar working on Cancer Research, Oncology, Virology, Epidemiology and Health Informatics, having authored 107 papers that have together received 8.3k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (70 papers), Cytomegalovirus and herpesvirus research (36 papers), Cancer-related molecular mechanisms research (28 papers), MicroRNA in disease regulation (19 papers), Circular RNAs in diseases (18 papers), Herpesvirus Infections and Treatments (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and Histiocytic Disorders and Treatments (9 papers). The work is most often cited by research in Oncology (5.7k citations), Epidemiology (4.4k citations), Cancer Research (1.8k citations), Virology (434 citations) and Infectious Diseases (1.3k citations). Rolf Renne has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Don Ganem, Brian Herndier, Jianhong Hu, Dean H. Kedes, Mark A. Samols, Rebecca L. Skalsky, Michael Lagunoff, Dirk P. Dittmer, Isaac W. Boss and Weidong Zhong. Their work appears in journals such as Journal of Virology, PLoS Pathogens, Virology, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.